150 related articles for article (PubMed ID: 38515135)
1. Recent research advances in pain mechanisms in McCune-Albright syndrome thinking about the pain mechanism of FD/MAS.
Wang Y; Jiang T
J Orthop Surg Res; 2024 Mar; 19(1):196. PubMed ID: 38515135
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
[TBL] [Abstract][Full Text] [Related]
4. A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study.
Meier ME; Hagelstein-Rotman M; van de Ven AC; Van der Geest ICM; Donker O; Pichardo SEC; Hissink Muller PCE; van der Meeren SW; Dorleijn DMJ; Winter EM; van de Sande MAJ; Appelman-Dijkstra NM
Orphanet J Rare Dis; 2022 Dec; 17(1):439. PubMed ID: 36528764
[TBL] [Abstract][Full Text] [Related]
5. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract][Full Text] [Related]
6. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
[TBL] [Abstract][Full Text] [Related]
7. Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
Golden E; van der Heijden H; Ren B; Randall ET; Drubach LA; Shah N; Cay M; Ebb D; Kaban LB; Peacock ZS; Boyce AM; Mannstadt M; Upadhyay J
J Clin Endocrinol Metab; 2024 Feb; 109(3):771-782. PubMed ID: 37804088
[TBL] [Abstract][Full Text] [Related]
8. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.
Rotman M; Hamdy NAT; Appelman-Dijkstra NM
Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134
[TBL] [Abstract][Full Text] [Related]
9. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R
Bone; 2023 Sep; 174():116819. PubMed ID: 37301527
[TBL] [Abstract][Full Text] [Related]
10. Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Spencer TL; Watts L; Soni A; Pinedo-Villanueva R; Heegaard AM; Boyce AM; Javaid MK
J Clin Endocrinol Metab; 2022 May; 107(6):e2258-e2266. PubMed ID: 35262711
[TBL] [Abstract][Full Text] [Related]
11. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
12. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
[TBL] [Abstract][Full Text] [Related]
13. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.
Javaid MK; Boyce A; Appelman-Dijkstra N; Ong J; Defabianis P; Offiah A; Arundel P; Shaw N; Pos VD; Underhil A; Portero D; Heral L; Heegaard AM; Masi L; Monsell F; Stanton R; Dijkstra PDS; Brandi ML; Chapurlat R; Hamdy NAT; Collins MT
Orphanet J Rare Dis; 2019 Jun; 14(1):139. PubMed ID: 31196103
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
[TBL] [Abstract][Full Text] [Related]
15. Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications.
Szymczuk V; Taylor J; Boyce AM
Curr Osteoporos Rep; 2023 Apr; 21(2):147-153. PubMed ID: 36849642
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
[TBL] [Abstract][Full Text] [Related]
17. McCune-Albright syndrome with craniofacial dysplasia: Clinical review and surgical management.
Belsuzarri TA; Araujo JF; Melro CA; Neves MW; Navarro JN; Brito LG; Pontelli LO; de Abreu Mattos LG; Gonçales TF; Zeviani WM
Surg Neurol Int; 2016; 7(Suppl 6):S165-9. PubMed ID: 27057395
[TBL] [Abstract][Full Text] [Related]
18. Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).
Hagelstein-Rotman M; Meier ME; Majoor BCJ; Cleven AHG; Dijkstra PDS; Hamdy NAT; van de Sande MAJ; Dekkers OM; Appelman-Dijkstra NM
Calcif Tissue Int; 2021 Mar; 108(3):346-353. PubMed ID: 33226445
[TBL] [Abstract][Full Text] [Related]
19. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
